Can PTC get away with a $35,000 price tag on a cheap, old overseas steroid for Duchenne?
PTC Therapeutics $PTCT thinks it can roll out the steroid deflazacort for $35,000 a year, undercutting the $89,000 price that pushed Marathon Pharmaceuticals to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
